RADNOR, Pa., Feb. 7, 2012 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing innovative therapeutic drugs to treat serious acute-care conditions, will be presenting at the 14th Annual BIO CEO and Investor Conference. The Conference, which is the largest investor conference focused on established and emerging publicly traded biotech companies, will take place February 13-14, 2012 at the Waldorf Astoria in New York, NY.
